Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back

NCT00671502 Phase 3 COMPLETED Results posted

The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Details

Lead sponsor	Meda Pharmaceuticals
Phase	Phase 3
Status	COMPLETED
Enrolment	840
Start date	2008-04
Completion	2009-02

Conditions

• Lower Back Pain

Interventions

• Carisoprodol SR
• Carisoprodol SR
• Placebo

Primary outcomes

• Subject Rating of Pain on a 100-point Visual Analog Scale (VAS) — up to 14 days
  the scale used was from 0 to 100 mm. 0 equaled no pain and 100 equaled maximum pain.participants measure their pain before treatment and during treatment at each visit

Countries

United States